Why is BioNtech SE important to traders?
Learn all about BioNTech, with information on the company’s history and share price journey, its share trading hours, and how to trade BioNTech shares with Capital.com.
Learn more about BioNtech SETrade BioNtech SE - BNTX CFD
Add to favourite- Summary
- Historical Data
Trading сonditions
| Spread | 0.42 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.02629% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.004068% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
Key Stats
| Prev. Close | 84.55 |
| Open | 84.9 |
| 1-Year Change | -20.48% |
| Day's Range | 84.73 - 86 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Jul 25, 2024 | 84.27 | 1.67 | 2.02% | 82.60 | 85.83 | 82.23 |
| Jul 24, 2024 | 82.75 | -2.09 | -2.46% | 84.84 | 85.21 | 82.54 |
| Jul 23, 2024 | 84.64 | -0.90 | -1.05% | 85.54 | 86.08 | 83.63 |
| Jul 22, 2024 | 85.30 | -0.71 | -0.83% | 86.01 | 86.40 | 84.36 |
| Jul 19, 2024 | 86.03 | 0.25 | 0.29% | 85.78 | 86.08 | 84.95 |
| Jul 18, 2024 | 86.15 | -0.11 | -0.13% | 86.26 | 87.45 | 85.89 |
| Jul 17, 2024 | 86.45 | 0.19 | 0.22% | 86.26 | 87.66 | 84.95 |
| Jul 16, 2024 | 86.73 | 3.05 | 3.64% | 83.68 | 86.81 | 83.63 |
| Jul 15, 2024 | 83.65 | -1.70 | -1.99% | 85.35 | 85.59 | 83.05 |
| Jul 12, 2024 | 84.39 | -0.73 | -0.86% | 85.12 | 86.87 | 83.53 |
| Jul 11, 2024 | 83.95 | 2.89 | 3.57% | 81.06 | 85.33 | 80.69 |
| Jul 10, 2024 | 80.86 | 0.40 | 0.50% | 80.46 | 81.54 | 80.14 |
| Jul 9, 2024 | 80.12 | -0.04 | -0.05% | 80.16 | 81.03 | 79.81 |
| Jul 8, 2024 | 80.00 | -0.39 | -0.49% | 80.39 | 81.83 | 79.60 |
| Jul 5, 2024 | 79.59 | -1.55 | -1.91% | 81.14 | 81.14 | 79.21 |
| Jul 3, 2024 | 79.74 | 0.93 | 1.18% | 78.81 | 81.37 | 78.74 |
| Jul 2, 2024 | 78.80 | 0.38 | 0.48% | 78.42 | 79.36 | 77.96 |
| Jul 1, 2024 | 78.63 | -2.11 | -2.61% | 80.74 | 81.69 | 78.55 |
| Jun 28, 2024 | 79.97 | -0.72 | -0.89% | 80.69 | 81.44 | 79.97 |
| Jun 27, 2024 | 80.33 | -2.29 | -2.77% | 82.62 | 82.79 | 80.05 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
Trade commission
0
- 1:1
Leverage
1:1
- 20
- 100
- 500
- 1000
- 10000
Investment
Trade size (Leverage x Investement):
Open
Close
Short Long
Biontech SE Company profile
Discover the latest BioNTech stock price today with our interactive streaming chart.
Founded in 2008, BioNTech is an innovative biotechnology company from Germany, specialising in the research, development and producing of active individualised immunotherapies. The company adheres to a patient-specific approach to treatment of serious diseases, such as cancer.
BioNTech shares a vision that every patient’s tumour is unique. It means that each patient’s treatment should be individualised. To implement the scientists’ ideas into practice, BioNTech has developed pioneering therapeutics for cancer and other rare and infectious diseases.
Headquartered in Mainz, Germany, the company is aimed at becoming the world’s leading biotechnology company for individialised cancer treatment. By 2020, BioNTech had more than 440 patients treated across 17 tumour types. The company has more than 1,300 employees and seven pharmaceutical partners.
In August 2018, the company partnered with the US pharmaceutical giant Pfizer Inc to develop mRNA-based vaccines for preventing influenza. In September 2019, BioNTech started working on the development of tuberculosis and HIV programmes and preclinical vaccine and immunotherapy candidates for the prevention of tuberculosis and HIV infections under an agreement with the Bill & Melinda Gates Foundation.
BioNTech stock floated on the NASDAQ stock exchange through a $150m initial public offering (IPO) in October 2019. Since then the BNTX stock quote has been traded on the US market.
In November 2020, BioNTech and Pfizer triggered the strongest wave of optimism on the stock market after they announced that their Covid-19 vaccine showed 90 per cent effectiveness during the phase-three clinical trials. The BioNTech share price soared 14 per cent the day after the announcement.
In 2019, BioNTech reported total revenues of about €109m. According to the estimates from Morgan Stanley, BioNTech and Pfizer can make around $13bn from vaccine sales, getting $6.5bn each if these estimates are correct.
Looking closely at the BioNTech stock price chart in 2020, we can see that BNTX stock has been trading in a range of $18.60-$115. Since the large sell-off in March 2020, the BioNTech SE (BNTX) stock quote grew from $28.55 on March 12, 2020, to $112.76 on November 10, 2020, which is a growth of 294 per cent.
Follow the BioNTech share price live on our interactive share price chart and build your own forecast for the famous German biotechnology company. Follow the latest BioNTech share news and spot the best levels to open profitable CFD trades at Capital.com.
| Industry: | Bio Therapeutic Drugs |
An der Goldgrube 12
MAINZ
RHEINLAND-PFALZ 55131
DE
News
How to manage risk when trading
Learn what risk management is and find out how understanding about it could help you identify potential risks in your investment portfolio. Find out more.
06:57, 22 July 2024
ECB preview: lack of new data sees markets expecting a hold
Markets expect the ECB to keep rates unchanged in July but expectations for a September cut rise
13:13, 18 July 2024
What is an IPO and how does it work?
Learn about what an IPO is, why they are important, and how they work.
07:19, 10 July 2024
What are the biggest stock exchanges worldwide?
Discover the largest stock exchanges in the world by market capitalisation, including the Nasdaq Stock Market, the New York Stock Exchange and the London Stock Exchange.
12:44, 9 July 2024
Top ETFs
ETFs, or exchange-traded funds, offer traders a versatile gateway into the financial markets.
16:23, 8 July 2024
Lloyds forecast: will Lloyds share price return to £1? Third party data forecast
What’s next for Lloyds amid higher inflation and the start of a potential recessionary cycle in the UK?
14:00, 8 July 2024
RBNZ Preview: OCR expected to remain unchanged as central bank focuses on inflation
The Reserve Bank of New Zealand meets on Wednesday, July 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.
13:25, 8 July 2024People also watch
Still looking for a broker you can trust?
Join the 630,000+ traders worldwide that chose to trade with Capital.com